Magee-Womens Research Institute and Hamot Health Foundation are moving closer to putting Erie on the map for scientific cancer research.

At the annual Seeds of Hope luncheon at the Bayfront Convention Center on Tuesday, supporters of that idea heard from some of the country's best scientists, researchers and oncologists.

They learned about the latest women's cancer treatments under study at Magee-Womens Research Institute.  That includes work on a vaccine to prevent ovarian cancer, new therapeutic treatments for patients with ovarian cancer and a work on a breast cancer compound that is showing promise in blocking metastases or spread of the disease to the brain and other parts of the body.

Michael Annichine, CEO Magee-Womens Research Institute emphasized the importance of clinical trials in advancing these treatments from compounds to medications for the women who need them most. "When you have an opportunity to get engaged or get involved with a clinical trial you really should think about--can you take advantage of that, because that's the cutting edge, those are the best of the best and every year we come up with less invasive, more effective drugs."

Look for an announcement soon about the continuing connection between Magee-Womens at UPMC Hamot, Magee-Womens Research Institute in Pittsburgh and cancer patients right here in Erie.